MedtronicMDT
MDT
About: One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Employees: 95,000
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
63% more first-time investments, than exits
New positions opened: 204 | Existing positions closed: 125
39% more funds holding in top 10
Funds holding in top 10: 31 [Q4 2024] → 43 (+12) [Q1 2025]
17% more repeat investments, than reductions
Existing positions increased: 921 | Existing positions reduced: 784
14% more capital invested
Capital invested by funds: $85.1B [Q4 2024] → $96.9B (+$11.8B) [Q1 2025]
2% more funds holding
Funds holding: 2,088 [Q4 2024] → 2,121 (+33) [Q1 2025]
1% more call options, than puts
Call options by funds: $1.05B | Put options by funds: $1.04B
0.23% less ownership
Funds ownership: 83.02% [Q4 2024] → 82.79% (-0.23%) [Q1 2025]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$90
3%
upside
Avg. target
$95
9%
upside
High target
$101
16%
upside
4 analyst ratings
2 positive
50%
2 neutral
50%
0 negative
0%
Mizuho Anthony Petrone | 12%upside $98 | Outperform Maintained | 22 May 2025 |
RBC Capital Shagun Singh | 16%upside $101 | Outperform Maintained | 22 May 2025 |
Baird David Rescott | 5%upside $92 | Neutral Maintained | 22 May 2025 |
Truist Securities Richard Newitter | 3%upside $90 | Hold Maintained | 11 Apr 2025 |
Financial journalist opinion
Based on 37 articles about MDT published over the past 30 days
Positive
Benzinga
1 day ago
Medtronic Is Separating Its Diabetes Business - Good News For Investors
Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction – an initial minority IPO carve-out followed by a split-off of the remaining stake.
Positive
The Motley Fool
1 day ago
3 Monster Dividend Stocks to Hold for the Next 10 Years
The S&P 500 index (^GSPC 0.38%) is offering a minuscule 1.2% average yield today. That's not much to support a dividend-focused investor's income needs and speaks to a market that is richly valued.
Positive
The Motley Fool
1 day ago
Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Stock Instead?
Several years ago I bought shares of 3M (MMM -1.73%) even though it was in the middle of a major class-action lawsuit. I believed the industrial giant would survive the legal issues, which it has.
Neutral
PRNewsWire
2 days ago
Medtronic announces MiniMed as name for planned New Diabetes Company
GALWAY, Ireland , June 12, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001, and a deep 40-year history of being at the forefront of transforming diabetes care around the world.
Negative
The Motley Fool
3 days ago
5 Things You Need to Know If You Buy Medtronic Today
Medtronic (MDT 0.54%) is a large medical device maker, but its stock hasn't performed particularly well of late. After hitting a peak in 2021, the stock fell nearly 50% and has since moved roughly sideways.
Positive
The Motley Fool
3 days ago
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Volatility is a part of life for long-term investors. The reasons the market goes up or down change, but the constant is that high-quality stocks, businesses that increasingly make more money over time, will reward investors if you wait long enough.
Positive
Forbes
5 days ago
Medtronic Announces Intent To Spin Diabetes Business
Deal OverviewOn May 21, 2025, Medtronic plc (NYSE: MDT; $87.44, Market Capitalization: $112.1 billion), a global leader in medical technology, announced its intent to spin off its Diabetes business into a standalone entity (New Diabetes Company). This strategic move is designed to streamline Medtronic's portfolio, sharpen its focus on high-margin growth areas, and unlock shareholder value.
Positive
The Motley Fool
1 week ago
Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
Some stock-trading platforms enable their users to automatically replicate the positions taken by experienced investors or other famous figures. Many investors might prefer to do their own research before buying shares of a company, but it's still a good idea to pay attention to some of the moves more experienced names on Wall Street make.
Positive
The Motley Fool
1 week ago
Medtronic Just Announced a Move That Its Shareholders Should Love
Medtronic (MDT 0.12%) is a medical device company with vast and diverse operations. Its business is fairly stable although the stock's returns haven't been all that great.
Positive
Seeking Alpha
1 week ago
Caterpillar To Lead Dividend Increases In June As Lowe's Boosted Payout At End Of May
Dividend growth remains robust for select companies, with Casey's, Oil-Dri, and Matson poised for double-digit increases based on strong earnings and expansion. Caterpillar and Kroger are expected to deliver mid-to-high single-digit dividend hikes, reflecting solid but moderating earnings and macroeconomic headwinds. Target and John Wiley will likely announce minimal dividend increases, as flat sales and earnings pressure payout growth, but their long streaks of increases remain intact.
Charts implemented using Lightweight Charts™